echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cardiovasc Diabetol: Synergistic effects of chronic kidney disease, neuropathy and retinopathy on all-cause mortality in diabetic patients

    Cardiovasc Diabetol: Synergistic effects of chronic kidney disease, neuropathy and retinopathy on all-cause mortality in diabetic patients

    • Last Update: 2022-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The prognostic value of common diabetes-related microvascular complications (MVCs), namely chronic kidney disease (CKD), cardiac autonomic neuropathy (CAN), peripheral neuropathy (DPN), and retinopathy (DR), is well established
    .
    However, the effects of different combinations of these complications on long-term mortality have not been adequately assessed
    .

    The researchers retrospectively analyzed 21 years of longitudinal data from 303 patients with type 1 or type 2 diabetes mellitus (T1D, T2D) who had clear certainty about the presence or absence of microvascular complications at baseline by 99 mTc-DTPA dynamic renal imaging, nocturnal urine collection, cardiovascular autonomic testing, monofilament testing, and dilated fundus examination
    .


    The effect of single microvascular complications on all-cause mortality

    After 5244 person-years of follow-up, a total of 133 patients (43.
    9%) died
    .
    The presence of chronic kidney disease and cardiac autonomic neuropathy increases the risk of corrected all-cause mortality by 117% and 54%,
    respectively, regardless of other microvascular complications.
    Concomitant chronic kidney disease and cardiac autonomic neuropathy were associated with the highest risk of death at baseline (HR 5.
    08 [2.
    52–10.
    26]), followed by chronic kidney disease and retinopathy (HR 2.
    95 [1.
    63–5.
    32]) and cardiac autonomic neuropathy and retinopathy (HR 2.
    07 [1.
    11–3.
    85]).

    The risk of death (HR 1.
    52 [0.
    87 to 2.
    67]) was numerically higher in patients with any single microvascular complication than in patients without microvascular complications, and the risk of death was increased by 203% (HR 3.
    03 [1.
    62 to 5.
    68]) and 692% (HR 7.
    92 [2.
    93 to 21.
    37]),
    respectively, in patients with two and three microvascular complications.


    Effect of multiple microvascular complications on all-cause mortality in patients

    This study demonstrates the long-term, synergistic, and negative effects of single and multiple diabetic microvascular complications on all-cause mortality in patients with diabetes, suggesting that patients with T1D and T2D should be screened for comprehensive microvascular complications to improve risk stratification and treatment
    .

    Original source:

    Sacchetta, L.
    , Chiriacò, M.
    , Nesti, L.
    et al.
    Synergistic effect of chronic kidney disease, neuropathy, and retinopathy on all-cause mortality in type 1 and type 2 diabetes: a 21-year longitudinal study.
    Cardiovasc Diabetol 21, 233 (2022).
    https://doi.
    org/10.
    1186/s12933-022-01675-6

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.